Loews Corp’s CVS Health CVS Stock Holding History

Loews Corp’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-45,000	Closed	-$4.55M	–	37
2022 Q1	$4.55M	Sell	45,000 -120,000	-73%	-$12.6M	0.04%	29
2021 Q4	$17M	Sell	165,000 -105,000	-39%	-$9.7M	0.15%	15
2021 Q3	$22.9M	Sell	270,000 -10,000	-4%	-$838K	0.21%	5
2021 Q2	$23.4M	Hold	280,000	–	–	0.2%	6
2021 Q1	$21.1M	Buy	280,000 +43,000	+18%	+$3.13M	0.19%	7
2020 Q4	$16.2M	Sell	237,000 -3,000	-1%	-$195K	0.16%	13
2020 Q3	$14M	Sell	240,000 -10,000	-4%	-$622K	0.18%	10
2020 Q2	$16.2M	Buy	250,000 +190,000	+317%	+$12M	0.2%	8
2020 Q1	$3.56M	Buy	60,000 +10,000	+20%	+$668K	0.04%	32
2019 Q4	$3.71M	Sell	50,000 -20,000	-29%	-$1.4M	0.03%	41
2019 Q3	$4.42M	Sell	70,000 -10,000	-13%	-$593K	0.03%	39
2019 Q2	$4.36M	Buy	80,000 +75,680	+1,752%	+$4.08M	0.03%	40
2019 Q1	$233K	Hold	4,320	–	–	﹤0.01%	114
2018 Q4	$283K	Buy	+4,320	New	+$322K	﹤0.01%	104
2017 Q4	–	Sell	-230,000	Closed	-$18.7M	–	163
2017 Q3	$18.7M	Sell	230,000 -20,000	-8%	-$1.58M	0.12%	6
2017 Q2	$20.1M	Buy	+250,000	New	+$19.7M	0.13%	5

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Loews Corp's CVS Position: Q2 2022 in Review

Loews Corp sold out of CVS Health (CVS) in Q2 2022, closing a stake of 45,000 shares — an estimated $4.55M sold.

Loews Corp first reported a position in CVS in Q2 2017 and held it in 16 quarters. The position peaked at $23.4M in Q2 2021. 2,310 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Loews Corp reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
Loews Corp sold 45,000 CVS Health shares in Q2 2022, an estimated $4.55M.
Loews Corp first reported a position in CVS Health in Q2 2017 and held it in 16 quarters.
Loews Corp's CVS Health position peaked at $23.4M in Q2 2021.
2,310 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Loews Corp's 13F filing for Q2 2022, filed 9 Aug 2022.